Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 652 | 350 | 0 |
| Gross Profit | 652 | 350 | N/A |
| Operating Expenses | 53,740 | 52,229 | 45,001 |
| Operating Income | -53,088 | -51,879 | -45,001 |
| Other Income | 1,297 | 2,588 | 809 |
| Pre-tax Income | -51,791 | -49,291 | -44,192 |
| Net Income Continuous | -51,791 | -49,291 | -44,192 |
| Net Income | $-51,791 | $-49,291 | $-44,192 |
| EPS Basic Total Ops | -11.04 | -124.80 | -141.51 |
| EPS Basic Continuous Ops | -11.04 | -124.79 | -141.51 |
| EPS Diluted Total Ops | -11.04 | -124.80 | -141.51 |
| EPS Diluted Continuous Ops | -11.04 | -124.79 | -141.51 |
| EPS Diluted Before Non-Recurring Items | -11.04 | N/A | N/A |
| EBITDA(a) | $-51,392 | $-50,201 | $-44,123 |